Allergan buys rights to Merck’s migraine drugs
July 07, 2015 at 07:47 AM EDT
Upfront payments of $250 million for 2 experimental treatments in development.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.